18 - New Antimicrobials and ID Diagnostics in the Pipeline - Bacterial

Thursday, October 20, 2022

8:00 AM – 9:00 AM US ET

Location: 145 AB

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Moderator(s)

Cesar Arias, MD, PhD

Professor
Division of Infectious Diseases, Department of Medicine.
Houston Methodist Hospital and Weill Cornell Medical College
Houston, TX, United States

Disclosure(s): Entasis: Grant/Research Support (); MeMed Diagnostics Ltd: Grant/Research Support (); Merck: Grant/Research Support ()
David van Duin, MD, PhD

Professor of Medicine
Department of Medicine
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States

Disclosure(s): Achaogen: Advisor/Consultant (); Actavis: Advisor/Consultant (); Allergan: Advisor/Consultant (); Astellas: Advisor/Consultant (); Entasis: Advisor/Consultant (); Karius: Advisor/Consultant (); MedImmune: Advisor/Consultant (); Merck: Advisor/Consultant (), Grant/Research Support (); Neumedicine: Advisor/Consultant (); Pfizer: Advisor/Consultant (), Honoraria (); Qpex: Advisor/Consultant (); Roche: Advisor/Consultant (); Sanofi-Pasteur: Advisor/Consultant (); Shionogi: Advisor/Consultant (), Grant/Research Support (); T2Biosystems: Advisor/Consultant (); Tetraphase: Advisor/Consultant (); Utility: Advisor/Consultant (); Wellspring: Advisor/Consultant ()
Christine Johnston, MD, MPH

Associate Professor
Medicine
University of Washington
Seattle, Washington, United States

Disclosure(s): Abbvie: Advisor/Consultant (Terminated); Gilead Biosciences: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); GSK: Advisor/Consultant (Ongoing); UpToDate Wolters Kluwer Health: Royalties (Ongoing)

Faculty(s)

BM

Barbara McGovern, MD

Vice President
Seres Therapeutics, Inc.
Cambridge, MA, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.
Helen Bright, PhD (she/her/hers)

VP of R&D
Centauri Therapeutics
Cheshire, England, United Kingdom

Disclosure(s): Medimmune/AstraZeneca: Employee (Terminated), Stocks/Bonds (Terminated)

Slides
Kevin Garey, PharmD, MS (he/him/his)

Professor and Chair
Department of Pharmacy Practice and Translational Research
University of Houston
Houston, TX, United States

Disclosure(s): Acurx: Grant/Research Support (); cidara: Advisor/Consultant (), Grant/Research Support (); Paratek: Grant/Research Support (); Seres Health: Grant/Research Support (); Summit: Grant/Research Support ()

Slides
Paul McGovern, MD

Senior Vice President, Medical Sciences
Venatorx Pharmaceuticals
Malvern, PA, United States

Disclosure(s): Paratek Pharmaceuticals: Stocks/Bonds (); Venatorx Pharmaceuticals: employee (), Stocks/Bonds ()

Slides
Nicole Scangarella-Oman, MS (she/her/hers)

Scientific Director
GSK
Collegeville, PA, United States

Disclosure(s): GSK: Employee (Ongoing), Stocks/Bonds (Ongoing)

Slides
Paul Eckburg, MD (he/him/his)

Chief Medical Officer
AN2 Therapeutics, Inc.
Menlo Park, CA, United States

Disclosure(s): Adaptive Phage Therapeutics (APT): Advisor/Consultant (Ongoing); Bugworks Research: Advisor/Consultant (Ongoing); Curza: Advisor/Consultant (Ongoing); Paratek Pharmaceuticals: Safety Monitoring Board (Ongoing); SNIPR Biome: Advisor/Consultant (Terminated); Spero Therapeutics: Advisor/Consultant (Terminated)

Slides

Disclosure(s):

Cesar A. Arias, MD, PhD: Entasis: Grant/Research Support (); MeMed Diagnostics Ltd: Grant/Research Support (); Merck: Grant/Research Support ()

David van Duin, MD, PhD: Achaogen: Advisor/Consultant (); Actavis: Advisor/Consultant (); Allergan: Advisor/Consultant (); Astellas: Advisor/Consultant (); Entasis: Advisor/Consultant (); Karius: Advisor/Consultant (); MedImmune: Advisor/Consultant (); Merck: Advisor/Consultant (), Grant/Research Support (); Neumedicine: Advisor/Consultant (); Pfizer: Advisor/Consultant (), Honoraria (); Qpex: Advisor/Consultant (); Roche: Advisor/Consultant (); Sanofi-Pasteur: Advisor/Consultant (); Shionogi: Advisor/Consultant (), Grant/Research Support (); T2Biosystems: Advisor/Consultant (); Tetraphase: Advisor/Consultant (); Utility: Advisor/Consultant (); Wellspring: Advisor/Consultant ()

Christine Johnston, MD, MPH: Abbvie: Advisor/Consultant (Terminated); Gilead Biosciences: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); GSK: Advisor/Consultant (Ongoing); UpToDate Wolters Kluwer Health: Royalties (Ongoing)

Helen Bright, PhD: Medimmune/AstraZeneca: Employee (Terminated), Stocks/Bonds (Terminated)

Kevin W. Garey, PharmD, MS: Acurx: Grant/Research Support (); cidara: Advisor/Consultant (), Grant/Research Support (); Paratek: Grant/Research Support (); Seres Health: Grant/Research Support (); Summit: Grant/Research Support ()

Paul C. McGovern, MD: Paratek Pharmaceuticals: Stocks/Bonds (); Venatorx Pharmaceuticals: employee (), Stocks/Bonds ()

Nicole E. Scangarella-Oman, MS: GSK: Employee (Ongoing), Stocks/Bonds (Ongoing)

Paul B. Eckburg, MD: Adaptive Phage Therapeutics (APT): Advisor/Consultant (Ongoing); Bugworks Research: Advisor/Consultant (Ongoing); Curza: Advisor/Consultant (Ongoing); Paratek Pharmaceuticals: Safety Monitoring Board (Ongoing); SNIPR Biome: Advisor/Consultant (Terminated); Spero Therapeutics: Advisor/Consultant (Terminated)

No CE credits offered

Presentations:

8:00 AM – 8:10 AM US ET

ABX-01, a novel immunotherapy to treat Gram-negative infections
Speaker: Helen Bright, PhD (she/her/hers) – Centauri Therapeutics
8:10 AM – 8:20 AM US ET

Cefepime-Taniborbactam, Venatorx Pharmaceuticals, Inc.
Speaker: Paul C. McGovern, MD – Venatorx Pharmaceuticals
8:20 AM – 8:30 AM US ET

Epetraborole
Speaker: Paul B. Eckburg, MD (he/him/his) – AN2 Therapeutics, Inc.
8:30 AM – 8:40 AM US ET

Gepotidacin, GSK
Speaker: Nicole E. Scangarella-Oman, MS (she/her/hers) – GSK
8:40 AM – 8:50 AM US ET

Ibezapolstat; Acurx Pharmaceuticals
Speaker: Kevin W. Garey, PharmD, MS (he/him/his) – University of Houston
8:50 AM – 9:00 AM US ET

SER-109, an Oral Investigational Microbiome Therapy for the Prevention of Recurrent Clostridioides difficile Infection. Seres Therapeutics
Speaker: Barbara McGovern, MD – Seres Therapeutics, Inc.